These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 36427655)

  • 1. Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells.
    Huang H; Zhang Y; Xu X; Liu Y; Zhao J; Ma L; Lei J; Ge W; Li N; Ma E; Li Y; Yuan L
    Bioorg Med Chem Lett; 2023 Jan; 80():129087. PubMed ID: 36427655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S.
    Yuan L; Zhao J; Zhao S; Dong T; Dong R; Liu D; Ma E; Li Y
    Chem Biol Interact; 2022 Feb; 353():109811. PubMed ID: 35016848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel cathepsin inhibitors with potent anti-metastatic effects in breast cancer cells.
    Yuan L; Sheng L; He W; Zou C; Hu B; Liu J; Ge W; Liu Y; Wang J; Ma E
    Bioorg Chem; 2018 Dec; 81():672-680. PubMed ID: 30253340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of a novel and selective cathepsin L inhibitor with anti-metastatic ability in vitro and in vivo against breast cancer cells.
    Li Y; Ai X; Zou C; Liu Y; Ma L; Men J; Liu D; Sheng L; Ruan X; Liu H; Li W; Ma E; Yuan L
    Bioorg Chem; 2021 Oct; 115():105256. PubMed ID: 34426153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of a novel cathepsin inhibitor with dual autophagy-inducing and metastasis-inhibiting effects on breast cancer cells.
    Yuan L; Liu J; He W; Bao Y; Sheng L; Zou C; Hu B; Ge W; Liu Y; Wang J; Lin B; Li Y; Ma E
    Bioorg Chem; 2019 Mar; 84():239-253. PubMed ID: 30503850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biochemical evaluation of benzoylbenzophenone thiosemicarbazone analogues as potent and selective inhibitors of cathepsin L.
    Parker EN; Song J; Kishore Kumar GD; Odutola SO; Chavarria GE; Charlton-Sevcik AK; Strecker TE; Barnes AL; Sudhan DR; Wittenborn TR; Siemann DW; Horsman MR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem; 2015 Nov; 23(21):6974-92. PubMed ID: 26462052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of catalase on migration and invasion of lung cancer cells by regulating the activities of cathepsin S, L, and K.
    Tsai JY; Lee MJ; Dah-Tsyr Chang M; Huang H
    Exp Cell Res; 2014 Apr; 323(1):28-40. PubMed ID: 24583396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of novel human cathepsin S inhibitors on cell migration in human cancer cells.
    Tsai JY; Lee MJ; Chang MD; Wang HC; Lin CC; Huang H
    J Enzyme Inhib Med Chem; 2014 Aug; 29(4):538-46. PubMed ID: 24083411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinazoline derivatives as cathepsins B, H and L inhibitors and cell proliferating agents.
    Raghav N; Jangra S; Kumar A; Bhattacharyya S
    Int J Biol Macromol; 2017 Jan; 94(Pt A):719-727. PubMed ID: 27780761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active cathepsins B, L, and S in murine and human pancreatitis.
    Lyo V; Cattaruzza F; Kim TN; Walker AW; Paulick M; Cox D; Cloyd J; Buxbaum J; Ostroff J; Bogyo M; Grady EF; Bunnett NW; Kirkwood KS
    Am J Physiol Gastrointest Liver Physiol; 2012 Oct; 303(8):G894-903. PubMed ID: 22899821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.
    Wang Y; Xue S; Li R; Zheng Z; Yi H; Li Z
    Bioorg Med Chem; 2018 Jan; 26(1):8-16. PubMed ID: 29223717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of specific HDAC6 inhibitor with anti-metastatic effects in pancreatic cancer cells through virtual screening and biological evaluation.
    Song H; Niu X; Quan J; Li Y; Yuan L; Wang J; Ma C; Ma E
    Bioorg Chem; 2020 Apr; 97():103679. PubMed ID: 32120077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors.
    Wang Z; Shi J; Zhu X; Zhao W; Gong Y; Hao X; Hou Y; Liu Y; Ding S; Liu J; Chen Y
    Bioorg Chem; 2020 Dec; 105():104371. PubMed ID: 33075664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiproliferative potential of
    Sayed AM; El-Hawary SS; Abdelmohsen UR; Ghareeb MA
    Food Funct; 2022 Nov; 13(22):11733-11743. PubMed ID: 36281695
    [No Abstract]   [Full Text] [Related]  

  • 16. Design, synthesis, and biological evaluation of 2,6,7-substituted pyrrolo[2,3-d]pyrimidines as cyclin dependent kinase inhibitor in pancreatic cancer cells.
    Shi X; Quan Y; Wang Y; Wang Y; Li Y
    Bioorg Med Chem Lett; 2021 Feb; 33():127725. PubMed ID: 33316409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR studies of some acetophenone phenylhydrazone based pyrazole derivatives as anticathepsin agents.
    Raghav N; Singh M
    Bioorg Chem; 2017 Dec; 75():38-49. PubMed ID: 28915464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis and Biological Evaluation of Coumarin Derivatives as NEDD8 Activating Enzyme Inhibitors in Pancreatic Cancer Cells.
    Gong L; Lu P; Lu C; Li M; Wan H; Wang Y
    Med Chem; 2022; 18(6):679-693. PubMed ID: 34895126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification and pre-clinical testing of a reversible cathepsin protease inhibitor reveals anti-tumor efficacy in a pancreatic cancer model.
    Elie BT; Gocheva V; Shree T; Dalrymple SA; Holsinger LJ; Joyce JA
    Biochimie; 2010 Nov; 92(11):1618-24. PubMed ID: 20447439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis.
    Yuan L; Zou C; Ge W; Liu Y; Hu B; Wang J; Lin B; Li Y; Ma E
    Bioorg Chem; 2020 Jan; 94():103417. PubMed ID: 31744600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.